Search Results - "Stringer, Frances" :: K.UTB vyhledávací portál

The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent

by Stringer, Frances, Scott, Graham, Valbuena, Marian, Kinley, Judith, Nishihara, Mitsuhiro, Urquhart, Richard
Published in European journal of clinical pharmacology (01.03.2013)

Get full text

Journal Article

Loading…

Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist sipoglitazar

by Stringer, Frances, Ploeger, Bart A, DeJongh, Joost, Scott, Graham, Urquhart, Richard, Karim, Aziz, Danhof, Meindert
Published in Journal of clinical pharmacology (01.03.2013)

Get more information

Journal Article

Loading…

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

by Montvida, Olga, Shaw, Jonathan, Atherton, John J, Stringer, Frances, Paul, Sanjoy K
Published in Diabetes care (01.01.2018)

Get full text

Journal Article

Loading…

A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar

by Stringer, Frances, DeJongh, Joost, Scott, Graham, Danhof, Meindert
Published in Journal of clinical pharmacology (01.04.2014)

Get more information

Journal Article

Loading…

Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes

by Stringer, Frances, DeJongh, Joost, Enya, Kazuaki, Koumura, Emiko, Danhof, Meindert, Kaku, Kohei
Published in Diabetes technology & therapeutics (01.03.2015)

Get more information

Journal Article

Loading…

Comparison of normal and reversed-phase solid phase extraction methods for extraction of β-blockers from plasma using molecularly imprinted polymers

by MARTIN, Paul D, JONES, Graeme R, STRINGER, Frances, WILSON, Ian D
Published in Analyst (London) (01.04.2003)

Get full text

Journal Article

The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent

Evaluation of the impact of UGT polymorphism on the pharmacokinetics and pharmacodynamics of the novel PPAR agonist sipoglitazar

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar

Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetes

Comparison of normal and reversed-phase solid phase extraction methods for extraction of β-blockers from plasma using molecularly imprinted polymers

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database